Funding for this research was provided by:
the National Natural Science Foundation of China (81301119)
the Application Research of Capital Clinical Characteristics (Z181100001718082)
the Beijing Municipal Administration of Hospitals’ Youth Programme (QML20160504)
the China Association Against Epilepsy-UCB Research Fund (CAAE- UCB2016008)
the Natural Science Foundation of Capital Medical University (PYZ2017055)
Received: 4 October 2019
Accepted: 21 March 2020
First Online: 30 March 2020
Ethics approval and consent to participate
: The study was approved by the Medical Ethics Committee of Beijing Tiantan Hospital, Capital Medical University, and was carried out in accordance with the Declaration of Helsinki. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. All participants gave written informed consent to participate.
: All participants provided written consent for publication for the publication of clinical details.
: On behalf of all authors, the corresponding author confirms no conflict of interest.